Basics Quanterix Corporation Quanterix Corp is a life science company. The company digitizing biomarker analysis with the goal of advancing the science of precision health. IPO Date: December 7, 2017 Sector: Healthcare Industry: Biotech Market Cap: $203.85M Activated in VL: True Average Daily Range Avg Daily Range: $0.78 | 3.07% Avg Daily Range (30 D): $0.22 | 4.17% Avg Daily Range (90 D): $0.23 | 3.71% Institutional Daily Volume Avg Daily Volume: .27M Avg Daily Volume (30 D): .59M Avg Daily Volume (90 D): .64M Trade Size Avg Trade Size (Sh.): 68 Avg Trade Size (Sh.) (30 D): 84 Avg Trade Size (Sh.) (90 D): 84 Institutional Trades Total Inst.Trades: 1,272 Avg Inst. Trade: $1.33M Avg Inst. Trade (30 D): $.55M Avg Inst. Trade (90 D): $1.04M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.26M Avg Closing Trade (30 D): $.55M Avg Closing Trade (90 D): $1.01M Avg Closing Volume: 45.91K     News May 23, 2025 @ 1:10 PM New Data and Deal Flow Signal a Turning Point for ... Source: Prnewswire Apr 28, 2025 @ 10:00 PM $HAREHOLDER ALERT: The M&A Class Action Firm Urges... Source: Monteverde & Associates Pc Apr 2, 2025 @ 10:50 PM $TOCKHOLDER ALERT: The M&A Class Action Firm Urges... Source: Monteverde & Associates Pc Feb 18, 2025 @ 8:30 PM Quanterix Corporation Announcement: If You Have Su... Source: N/A Feb 14, 2025 @ 11:30 PM $TOCKHOLDER ALERT: The M&A Class Action Firm Conti... Source: Monteverde & Associates Pc Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.3 $-.53 $-.3 Diluted EPS $-1.3 $-.53 $-.3 Revenue $ 135.69M $ 30.33M $ 35.16M Gross Profit $ 78.8M $ 16.42M $ 22.17M Net Income / Loss $ -47.79M $ -20.5M $ -11.63M Operating Income / Loss $ -65.99M $ -26.37M $ -14.77M Cost of Revenue $ 56.89M $ 13.92M $ 12.99M Net Cash Flow $ 31.26M $ 19.83M $ 27.37M PE Ratio